Your session is about to expire
← Back to Search
Verasense for Osteoarthritis
Study Summary
This trial will compare the use of a new technology, Verasense, to manual soft tissue balancing in total knee arthroplasty (TKA). The primary outcomes of interest are patient-reported outcomes and knee range of motion at 3 months, 6 months, 1 year, and 2 years.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is it possible to participate in this experiment?
"To be eligible to take part in this clinical trial, participants must have had a primary total knee replacement and range between 18-85 years old with osteoarthritis of the knee. A maximum of 130 people will partake."
Are any additional participants being accepted for this experiment?
"Data from clinicaltrials.gov reveals that this medical study, initially posted December 20th 2017 and most recently updated September 30th 2021, is not currently recruiting patients for trial participation. Nevertheless, there are 456 other trials searching for participants at the present moment."
Are participants of this experiment required to be 18 years or older?
"The minimum age of admission to this medical trial is 18 and the oldest potential participant can be no greater than 85 years old."
Share this study with friends
Copy Link
Messenger